Heranba Industries Ltd
Incorporated in 1994, Heranba Industries Ltd is engaged in the manufacturing of a diverse range of agrochemicals such as insecticides, herbicides, fungicides and public health products for pest control. [1]
- Market Cap ₹ 1,825 Cr.
- Current Price ₹ 456
- High / Low ₹ 562 / 278
- Stock P/E 18.2
- Book Value ₹ 235
- Dividend Yield 0.28 %
- ROCE 10.6 %
- ROE 7.83 %
- Face Value ₹ 10.0
Pros
Cons
- The company has delivered a poor sales growth of 4.88% over past five years.
- Dividend payout has been low at 5.44% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Part of BSE Allcap BSE Commodities BSE SmallCap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|
514 | 582 | 741 | 1,004 | 951 | 1,219 | 1,450 | 1,324 | 1,275 | 1,325 | |
470 | 534 | 653 | 873 | 822 | 997 | 1,190 | 1,163 | 1,178 | 1,183 | |
Operating Profit | 44 | 48 | 88 | 131 | 129 | 221 | 260 | 161 | 97 | 142 |
OPM % | 9% | 8% | 12% | 13% | 14% | 18% | 18% | 12% | 8% | 11% |
1 | 2 | 5 | 7 | 17 | 7 | 19 | 14 | 30 | 39 | |
Interest | 13 | 12 | 12 | 11 | 9 | 5 | 4 | 8 | 12 | 16 |
Depreciation | 4 | 4 | 5 | 6 | 8 | 15 | 20 | 23 | 25 | 27 |
Profit before tax | 28 | 35 | 76 | 122 | 129 | 208 | 255 | 144 | 90 | 138 |
Tax % | 39% | 41% | 39% | 38% | 24% | 26% | 26% | 24% | 27% | |
17 | 20 | 47 | 75 | 98 | 154 | 189 | 110 | 66 | 101 | |
EPS in Rs | 21.61 | 26.01 | 60.02 | 19.31 | 25.00 | 38.54 | 47.25 | 27.52 | 16.58 | 25.18 |
Dividend Payout % | 13% | 10% | 9% | 5% | 6% | 4% | 4% | 5% | 8% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 5% |
3 Years: | 2% |
TTM: | 6% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -3% |
3 Years: | -24% |
TTM: | 61% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -12% |
1 Year: | 27% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 21% |
3 Years: | 16% |
Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 8 | 8 | 8 | 39 | 39 | 40 | 40 | 40 | 40 | 40 |
Reserves | 91 | 108 | 150 | 189 | 282 | 488 | 674 | 776 | 837 | 901 |
96 | 84 | 76 | 50 | 43 | 52 | 91 | 93 | 144 | 193 | |
130 | 120 | 217 | 282 | 261 | 263 | 302 | 250 | 378 | 549 | |
Total Liabilities | 325 | 321 | 450 | 560 | 625 | 843 | 1,108 | 1,159 | 1,399 | 1,683 |
37 | 38 | 46 | 51 | 95 | 133 | 193 | 186 | 240 | 230 | |
CWIP | 0 | 0 | 1 | 16 | 38 | 10 | 14 | 42 | 11 | 14 |
Investments | 0 | 0 | 0 | 0 | 4 | 10 | 2 | 1 | 2 | 3 |
287 | 282 | 403 | 493 | 488 | 690 | 898 | 930 | 1,146 | 1,437 | |
Total Assets | 325 | 321 | 450 | 560 | 625 | 843 | 1,108 | 1,159 | 1,399 | 1,683 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
52 | 54 | 60 | 98 | 122 | 136 | ||||
-25 | -52 | -41 | -82 | -100 | -264 | ||||
-26 | -20 | 62 | -6 | -18 | 41 | ||||
Net Cash Flow | 1 | -18 | 82 | 10 | 4 | -87 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 102 | 78 | 100 | 92 | 99 | 102 | 112 | 107 | 143 |
Inventory Days | 76 | 86 | 68 | 60 | 83 | 78 | 100 | 122 | 100 |
Days Payable | 96 | 84 | 129 | 123 | 122 | 92 | 96 | 77 | 117 |
Cash Conversion Cycle | 83 | 79 | 39 | 29 | 61 | 89 | 116 | 152 | 125 |
Working Capital Days | 98 | 89 | 76 | 58 | 83 | 96 | 116 | 131 | 118 |
ROCE % | 24% | 41% | 52% | 43% | 45% | 37% | 18% | 11% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
18 Nov - Transcript of Earning Call held on November 15, 2024
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
15 Nov - Audio recording of earnings call available online.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Nov - Result for the Quarter ended on September 30, 2024 has been published in the Newspapers, details of which are given in the letter attached herewith
-
Proposed Incorporation Of JV Company
13 Nov - Approval for incorporation of a foreign joint venture in China.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
13 Nov - Investor presentation for Q2 FY2025 results.
Annual reports
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptNotesPPT
-
May 2024TranscriptNotesPPT
-
Feb 2024TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Jan 2022TranscriptNotesPPT
-
Dec 2021TranscriptPPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021Transcript PPT
Product Portfolio
Heranba is an agrochemical company in India. It manufactures Synthetic Pyrethroids and its intermediates in India. It has a portfolio of 370+ products comprising intermediates, technicals and formulations for insecticides, herbicides, fungicides, and public health products.